IMDRF Membership & International Alignment
SFDA and the IMDRF
The International Medical Device Regulators Forum (IMDRF) is a voluntary group of medical device regulators from around the world — including the US FDA, European Commission, Health Canada, TGA (Australia), PMDA (Japan), NMPA (China), and SFDA (Saudi Arabia) — that works to accelerate international regulatory harmonisation.
The SFDA is an active IMDRF member and applies IMDRF guidance in developing its own regulatory framework.
SFDA chairs the GHWP
The SFDA chairs the Global Harmonization Working Party (GHWP), a technical committee under the IMDRF umbrella focused on regulatory harmonisation in Asia-Pacific and Middle East markets. This reflects Saudi Arabia's growing role in global medical device regulation.
Implications of IMDRF alignment for manufacturers
IMDRF membership means the SFDA's framework draws heavily on internationally agreed regulatory principles:
- Classification rules aligned with IMDRF and EU MDR
- UDI requirements consistent with IMDRF UDI guidance
- Post-market surveillance and vigilance aligned with IMDRF PMS framework
- Clinical evaluation guidance consistent with IMDRF SaMD clinical evidence framework
This alignment benefits manufacturers who have already prepared documentation for IMDRF-member markets — much of the content can be leveraged for SFDA submissions.